1414958-09-0

Basic information

• Product Name: Trans-tert-butyl 3-aMino-4-Methylpiperidine-1-carboxylate
• Synonyms: Trans-tert-butyl 3-aMino-4-Methylpiperidine-1-carboxylate;(3S,4R)-tert-Butyl 3-amino-4-methylpiperidine-1-carboxylate
• CAS NO: 1414958-09-0
• Molecular Formula: C11H22N2O2
• Molecular Weight: 214.30458
• EINECS: -0
• Mol File: 1414958-09-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Trans-tert-butyl 3-aMino-4-Methylpiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Trans-tert-butyl 3-aMino-4-Methylpiperidine-1-carboxylate(1414958-09-0)
• EPA Substance Registry System: Trans-tert-butyl 3-aMino-4-Methylpiperidine-1-carboxylate(1414958-09-0)

Safety Data

• Hazardous Substances Data: 1414958-09-0(Hazardous Substances Data)

Upstream product

• 1207267-93-3 1-(tert-butoxycarbonyl)-3-methylpiperidine-4-carboxylic acid 
• 1038992-98-1 3-methylpiperidine-4-carboxylic acid hydrochloride 
• 24424-99-5 di-tert-butyl dicarbonate 
• 577993-80-7 3-methylpyridine-4-carboxylic acid hydrochloride 
• 116985-92-3 Methyl 3-methylpyridine-4-carboxylate 
• 512822-50-3 1-[(tert-butoxy)carbonyl]-3-methylpiperidine-4-carboxylic acid 
• 1824505-67-0 cis-N-BOC-3-methylpiperidine-4-carboxylic acid methyl ester 
• 1207267-93-3 cis-N-Boc-3-methylpiperidine-4-carboxylic acid 
• 4021-12-9 3-methyl-isonicotinic acid 
• 1824505-67-0 1-tert-butyl 4-methyl 3-methylpiperidine-1,4-dicarboxylate 
• 885951-69-9 3-methylpiperidine-4-carboxylic acid 
• 577993-80-7 3-methylpyridine-4-carboxylic acid hydrochloride 
• 512822-18-3 C₁₂H₂₁NO₃ 

Downstream Products

• 1082950-49-9 4-[4-(4-fluoro-3-trifluoromethylphenyl)-1H-imidazol-2-yl]-3-methylpiperidine-1-carboxylic acid tert-butyl ester 
• 1207267-93-3 (3R,4R)-1-(tert-butoxycarbonyl)-3-methylpiperidine-4-carboxylic acid 
• 1207267-93-3 (3S,4S)-1-(tert-butoxycarbonyl)-3-methylpiperidine-4-carboxylic acid 

Relevant articles and documents

SUBSTITUTED 4-PIPERIDINYL-QUINAZOLINES, 4-PIPERIDINYL-PYRIMIDINE-2-AMINES, AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS

The invention provides substituted 4-piperidinyl-quinazolines, 4-piperidinyl-pyrimidine-2-amines, and related compounds, pharmaceutical compositions, their use for inhibiting ERK5 activity, and their use in the treatment of medical disorders, such as cancer.

THERAPEUTIC METHODS AND COMPOUNDS

The invention provides a compound of formula I: (I) or a pharmaceutically acceptable salt thereof, wherein R1-R5 Y have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful to treat malaria.

COMPOUNDS USEFUL FOR ALTERING THE LEVELS OF BILE ACIDS FOR THE TREATMENT OF DIABETES AND CARDIOMETABOLIC DISEASE

Described herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as Cyp8b1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for diabetes and cardiovascular disease.